Wolverine Peptide Stack, Explained
"Wolverine stack" is a community nickname for BPC-157 plus TB-500. Here is where the name comes from, what is in it, how it is typically run, and what the evidence actually shows.
- BPC-157 + TB-500
- Mostly animal research
- Rx compounding allowed (draft policy)

Educational content only, not medical advice. BPC-157 and TB-500 are not FDA-approved. Talk to a licensed clinician before starting any peptide.
The quick summary
| What it is | BPC-157 and TB-500 (a thymosin beta-4 fragment), run together |
|---|---|
| Why the name | The X-Men character's fictional "healing factor" |
| Used for | Tissue repair, tendon and ligament injuries, recovery |
| Evidence | Animal research on each compound separately; no human trial of the pairing |
| Legal status (US) | Each can be compounded by prescription under the October 2026 draft HHS policy, as separate single-peptide products |
Where the name comes from
"Wolverine stack" is not a scientific or medical term. It is a nickname that grew up in the peptide community for combining BPC-157 and TB-500, both associated with tissue-repair research. Wolverine, the X-Men character, recovers from injury almost instantly thanks to a fictional healing factor.
The name captures the intent, not the evidence. No study has shown anything close to comic-book recovery in humans. The rest of this page covers what is actually known.
What's in it, and why pair them
Two peptides studied from different angles, combined on the idea that they cover each other.
Broad tissue repair
A synthetic peptide based on a fragment of a protein found in human gastric juice. Studied in animals for gut healing, tendon and ligament repair and inflammation.
Typical use: daily, often near the injury
Cell migration and blood flow
A synthetic fragment of thymosin beta-4, involved in actin regulation, cell migration and new blood vessel formation. Studied mostly in animal models.
Typical use: twice weekly, systemic
The "two angles" idea is reasoning across separate research on each compound. No study has tested the combination itself, so "better together" is a plausible hypothesis, not a demonstrated result.
How it's typically run
Common community and clinical-practice ranges, not human trial doses or a personal plan.
| BPC-157 | TB-500 | |
|---|---|---|
| Dose | 250 to 500mcg | 2 to 2.5mg |
| Frequency | Once daily | Twice weekly, non-consecutive days |
| Route | Subcutaneous, often near the injury | Subcutaneous |
| Length | 4 to 6 weeks | 4 to 6 weeks, sometimes a lower maintenance phase |
Full schedule, timing and maintenance phase in the BPC-157 + TB-500 stack guide. Syringe math: dosage calculator.
What the evidence actually shows
The part the nickname tends to hide.
A 2025 systematic review in sports medicine found the evidence is overwhelmingly preclinical, with very little human data.
Vasireddi et al., HSS J 2025 (PMID 40756949)
Early human trials (wounds, dry eye) tested the full-length molecule, not the TB-500 fragment people actually buy.
Goldstein et al., Trends Mol Med 2005 (PMID 16153892)
Legal status in 2026
- Prescription compounding: both are among the six peptides a 503A pharmacy can compound with a prescription under the October 2026 draft HHS policy.
- Two vials, not a blend: the policy allows one peptide per product, so a pharmacy cannot make a premixed "Wolverine" vial.
- Research chemicals: online "research use only" versions are not covered by the policy and are not tested for human use.
- Sport: both are on the WADA prohibited list, so tested athletes cannot use them.

Track the recovery
With an injury, you are going to improve over time anyway. Tracking is the only way to tell whether the stack added anything.
- Pain from 0 to 10, same activity, same time each day
- Range of motion or a simple function test, weekly
- Every dose, with injection site and any reactions
The Protocol Builder and dashboard log doses and check-ins together. Already running it? Rate My Stack.

Frequently asked questions
What is the Wolverine peptide stack?
An informal community nickname for combining BPC-157 and TB-500, two peptides studied mainly in animal research for tissue repair, wound healing and recovery. It is not a scientific or medical term and does not appear in clinical literature.
Why is it called the Wolverine stack?
The name references the X-Men character Wolverine, whose fictional mutant ability is near-instant healing. Because BPC-157 and TB-500 are both associated with tissue-repair research, the pairing picked up the nickname as shorthand for a fast-healing reputation, not because any study has shown Wolverine-like recovery in people.
What is the typical Wolverine stack dosage?
Common community and clinical-practice ranges are BPC-157 at 250 to 500mcg once daily and TB-500 at 2 to 2.5mg twice weekly, both subcutaneously, for about 4 to 6 weeks. These are not doses established in human trials, and a clinician should set any actual plan.
Is the Wolverine stack backed by human clinical trials?
No. BPC-157 has almost entirely animal research behind it, the human trials connected to TB-500 tested the full-length thymosin beta-4 molecule rather than the fragment that is sold, and no study has tested the two together. The stack's reputation rests on animal research and anecdote.
Why are BPC-157 and TB-500 combined instead of used alone?
BPC-157 has been studied broadly across many tissue types, while TB-500 has been studied for cell migration and new blood vessel formation through actin regulation. Combining them is thought to approach repair from two directions, but that rationale comes from reasoning across separate research, not from a study of the pairing.
Is the Wolverine stack legal?
In the US, BPC-157 and TB-500 are both covered by a draft HHS enforcement discretion policy published October 30, 2026, which lets licensed 503A pharmacies compound them for individual patients with a prescription. Each must be a separate single-peptide product, so a premixed blend is not covered. Research chemical versions sold online are not covered.
Can athletes use the Wolverine stack?
Not if they are drug tested. BPC-157 and TB-500 are both on the World Anti-Doping Agency prohibited list, at all times, in and out of competition.
Where can I find the full Wolverine stack protocol?
This page covers what the stack is and the evidence. For the full schedule, timing, maintenance phase and injection details, see the BPC-157 + TB-500 stack guide.
Where to buy: why blends are research-only, COA checks and today's price, in where to buy the Wolverine blend.
Plan it, then track it
Build a recovery protocol, log every dose and check-in, and see whether it is actually working. Free.
Sources
- Vasireddi N, et al. Emerging Use of BPC-157 in Orthopaedic Sports Medicine: A Systematic Review. HSS J. 2025. PMID 40756949
- Goldstein AL, Hannappel E, Kleinman HK. Thymosin beta4: actin-sequestering protein moonlights to repair injured tissues. Trends Mol Med. 2005;11(9):421-429. PMID 16153892
- U.S. Department of Health and Human Services. Enforcement Discretion Policy Regarding 503A Compounding Using Certain Peptide Bulk Drug Substances. Federal Register, October 30, 2026. federalregister.gov
- World Anti-Doping Agency. The Prohibited List. wada-ama.org
This content is for informational purposes only and is not medical advice. BPC-157 and TB-500 are not FDA-approved. Always consult a qualified healthcare provider before starting any peptide protocol.